Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
| Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-20370-6
9786610203703 0-309-55597-3 0-585-03433-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456250803321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg
| Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications |
| ISBN |
1-280-20370-6
9786610203703 0-309-55597-3 0-585-03433-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778503103321 |
| Washington, D.C. : , : National Academy Press, , 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
| Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications Pertussis Vaccine - adverse effects Rubella Vaccine - adverse effects |
| Soggetto genere / forma | Conference Proceedings. |
| ISBN |
9786610203703
9781280203701 1280203706 9780309555975 0309555973 9780585034331 0585034338 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Adverse Effects of Pertussis and Rubella Vaccines -- Copyright -- Preface -- Acknowledgments -- Contents -- Adverse Effects of PERTUSSIS and RUBELLA Vaccines -- 1 Executive Summary -- METHODOLOGIC CONSIDERATIONS IN EVALUATING THE EVIDENCE -- SUMMARY AND CONCLUSIONS -- RESEARCH NEEDS -- 2 Histories of Pertussis and Rubella Vaccines -- PERTUSSIS VACCINES -- Epidemiology of Whooping Cough -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Causative Organism, B. pertussis -- Major Milestones in the Development of Pertussis Vaccines -- Whole-Cell Vaccines -- Acellular Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Pertussis Vaccination -- RUBELLA VACCINES -- Epidemiology of the Disease Rubella -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Rubella Virus -- Major Milestones in the Development of Rubella Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Rubella Vaccination -- REFERENCES -- 3 Methodologic Considerations in Evaluating the Evidence -- THE NATURE OF THE EVIDENCE -- QUESTIONS TO BE ADDRESSED -- (1) Can vaccine cause the adverse event? -- (2) How frequently does vaccine cause the event? -- (3) Did vaccination cause a particular case of the adverse event? -- THE BURDEN OF PROOF -- CATEGORIES OF EVIDENCE -- Experiments in Humans -- Randomized Controlled Trials -- Other Experimental Studies -- Experiments in Animals: Animal Models -- Controlled Epidemiologic Studies (Observational) -- Cohort Studies -- Case-Comparison Studies -- Other Controlled Studies -- Case Reports and Case Series -- Searching for Patterns -- Historical Comparisons -- Causation of the Individual Case -- Monitoring System for Adverse Events Following Immunization -- ASSESSMENT OF THE EVIDENCE.
Evaluation of Single Studies -- Integration of the Collective Results -- Meta-Analysis -- Considerations in Inferring Causality -- THE NATURE OF THE CONCLUSIONS -- Quantitation -- Resolution -- Uncertainty and Confidence -- Quality -- Comprehensiveness -- Neutrality -- Judgment -- SUMMARY OF THE EVIDENCE -- REFERENCES -- 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile... -- INFANTILE SPASMS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- HYPSARRHYTHMIA -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ENCEPHALOPATHY -- Clinical Description -- Encephalopathy Following Whooping Cough -- Pathology -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Studies in Defined Populations -- The National Childhood Encephalopathy Study -- Other Controlled Studies in Humans -- Evidence from Studies in Animals -- Aluminum Salts -- Summary -- Conclusion -- REFERENCES -- 5 Evidence Concerning Pertussis Vaccines and Deaths Classified as Sudden Infant Death Syndrome -- CLINICAL DESCRIPTION, DIAGNOSIS, AND PATHOLOGY -- DESCRIPTIVE EPIDEMIOLOGY. HISTORY OF SUSPECTED ASSOCIATION WITH PERTUSSIS VACCINES -- EVIDENCE FROM STUDIES IN HUMANS -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- SUMMARY -- CONCLUSION -- REFERENCES -- 6 Evidence Concerning Pertussis Vaccines and Other Illnesses and Conditions -- ANAPHYLAXIS -- Clinical Description and Pathologic Aspects -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Controlled Epidemiologic Studies -- Evidence from Studies in Animals -- Endotoxin -- Summary -- Conclusion -- AUTISM -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Summary -- Conclusion -- ERYTHEMA MULTIFORME OR OTHER RASH -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Aluminum Salts -- Summary -- Conclusion -- GUILLAIN-BARRÉ SYNDROME (POLYNEUROPATHY) -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- PERIPHERAL MONONEUROPATHY -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- HEMOLYTIC ANEMIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- JUVENILE DIABETES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Report -- Evidence from Studies in Animals -- Summary -- Conclusion -- LEARNING DISABILITIES AND HYPERACTIVITY -- Clinical Description -- Learning Disability, Reading Disability, and Dyslexia -- Hyperactivity, Hyperkinesis, and Attention Deficit Disorder -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Controlled Epidemiologic Studies -- Summary. Conclusion -- PROTRACTED INCONSOLABLE CRYING AND SCREAMING -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusions -- REYE SYNDROME -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Reports and Case Series -- Summary -- Conclusion -- SHOCK AND ''UNUSUAL SHOCK-LIKE STATE" WITH HYPOTONICITY, HYPORESPONSIVENESS, AND SHORT-LIVED CONVULS ... -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- REFERENCES -- 7 Evidence Concerning Rubella Vaccines and Arthritis, Radiculoneuritis, and Thrombocytopenic Purpura -- ARTHRITIS -- Clinical Description and Pathologic Aspects -- Descriptive Epidemiology -- History of an Association with Rubella Vaccines -- Evidence from Studies in Humans -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Evidence from Studies in Animals -- Possible Mechanisms -- Summary -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Conclusions -- RADICULONEURITIS AND OTHER NEUROPATHIES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- THROMBOCYTOPENIC PURPURA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- REFERENCES -- Afterword on Research Needs -- Bibliography -- Glossary of Terms B -- Appendixes. A Strategies For Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines -- LITERATURE SEARCHES -- Electronic Data Bases -- OTHER SOURCES -- Reference Lists -- Presentations -- Public Meeting (January 10, 1990) -- Workshop (May 14, 1990) -- Committee Meeting (May 15, 1990) -- Additional Individuals and Organizations Who Provided Information -- Review of Interim Bibliography -- ABSTRACTION OF DATA FROM CASE REPORTS, CASE SERIES, AND CONTROLLED STUDIES -- Rationale -- Procedures for Abstraction and Adjudication of Study Data -- B Pertussis and Rubella Vaccines: A Brief Chronology -- PERTUSSIS VACCINES -- RUBELLA VACCINES -- REFERENCES -- C Animal Models for the Study of Whooping Cough and the Testing of Vaccine Materials -- ANIMAL MODELS FOR THE STUDY OF WHOOPING COUGH -- STANDARDIZED ANIMAL TESTS OF VACCINE MATERIALS -- REFERENCES -- D Technical Details of Power Calculations and Meta-Analyses -- POWER CALCULATIONS -- META-ANALYSES -- Formal Analysis -- Informal Analysis -- REFERENCES -- E Possible Involvement of Aluminum Salts in Erythema Multiforme, Encephalopathy, or Other Adverse E ... -- REFERENCES -- F Committee and Staff Biographies -- COMMITTEE -- STAFF -- Index. |
| Record Nr. | UNINA-9911098841403321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
| Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications Pertussis Vaccine - adverse effects Rubella Vaccine - adverse effects |
| Soggetto genere / forma | Conference Proceedings. |
| ISBN |
9786610203703
9781280203701 1280203706 9780309555975 0309555973 9780585034331 0585034338 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Adverse Effects of Pertussis and Rubella Vaccines -- Copyright -- Preface -- Acknowledgments -- Contents -- Adverse Effects of PERTUSSIS and RUBELLA Vaccines -- 1 Executive Summary -- METHODOLOGIC CONSIDERATIONS IN EVALUATING THE EVIDENCE -- SUMMARY AND CONCLUSIONS -- RESEARCH NEEDS -- 2 Histories of Pertussis and Rubella Vaccines -- PERTUSSIS VACCINES -- Epidemiology of Whooping Cough -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Causative Organism, B. pertussis -- Major Milestones in the Development of Pertussis Vaccines -- Whole-Cell Vaccines -- Acellular Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Pertussis Vaccination -- RUBELLA VACCINES -- Epidemiology of the Disease Rubella -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Rubella Virus -- Major Milestones in the Development of Rubella Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Rubella Vaccination -- REFERENCES -- 3 Methodologic Considerations in Evaluating the Evidence -- THE NATURE OF THE EVIDENCE -- QUESTIONS TO BE ADDRESSED -- (1) Can vaccine cause the adverse event? -- (2) How frequently does vaccine cause the event? -- (3) Did vaccination cause a particular case of the adverse event? -- THE BURDEN OF PROOF -- CATEGORIES OF EVIDENCE -- Experiments in Humans -- Randomized Controlled Trials -- Other Experimental Studies -- Experiments in Animals: Animal Models -- Controlled Epidemiologic Studies (Observational) -- Cohort Studies -- Case-Comparison Studies -- Other Controlled Studies -- Case Reports and Case Series -- Searching for Patterns -- Historical Comparisons -- Causation of the Individual Case -- Monitoring System for Adverse Events Following Immunization -- ASSESSMENT OF THE EVIDENCE.
Evaluation of Single Studies -- Integration of the Collective Results -- Meta-Analysis -- Considerations in Inferring Causality -- THE NATURE OF THE CONCLUSIONS -- Quantitation -- Resolution -- Uncertainty and Confidence -- Quality -- Comprehensiveness -- Neutrality -- Judgment -- SUMMARY OF THE EVIDENCE -- REFERENCES -- 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile... -- INFANTILE SPASMS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- HYPSARRHYTHMIA -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ENCEPHALOPATHY -- Clinical Description -- Encephalopathy Following Whooping Cough -- Pathology -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Studies in Defined Populations -- The National Childhood Encephalopathy Study -- Other Controlled Studies in Humans -- Evidence from Studies in Animals -- Aluminum Salts -- Summary -- Conclusion -- REFERENCES -- 5 Evidence Concerning Pertussis Vaccines and Deaths Classified as Sudden Infant Death Syndrome -- CLINICAL DESCRIPTION, DIAGNOSIS, AND PATHOLOGY -- DESCRIPTIVE EPIDEMIOLOGY. HISTORY OF SUSPECTED ASSOCIATION WITH PERTUSSIS VACCINES -- EVIDENCE FROM STUDIES IN HUMANS -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- SUMMARY -- CONCLUSION -- REFERENCES -- 6 Evidence Concerning Pertussis Vaccines and Other Illnesses and Conditions -- ANAPHYLAXIS -- Clinical Description and Pathologic Aspects -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Controlled Epidemiologic Studies -- Evidence from Studies in Animals -- Endotoxin -- Summary -- Conclusion -- AUTISM -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Summary -- Conclusion -- ERYTHEMA MULTIFORME OR OTHER RASH -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Aluminum Salts -- Summary -- Conclusion -- GUILLAIN-BARRÉ SYNDROME (POLYNEUROPATHY) -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- PERIPHERAL MONONEUROPATHY -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- HEMOLYTIC ANEMIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- JUVENILE DIABETES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Report -- Evidence from Studies in Animals -- Summary -- Conclusion -- LEARNING DISABILITIES AND HYPERACTIVITY -- Clinical Description -- Learning Disability, Reading Disability, and Dyslexia -- Hyperactivity, Hyperkinesis, and Attention Deficit Disorder -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Controlled Epidemiologic Studies -- Summary. Conclusion -- PROTRACTED INCONSOLABLE CRYING AND SCREAMING -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusions -- REYE SYNDROME -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Reports and Case Series -- Summary -- Conclusion -- SHOCK AND ''UNUSUAL SHOCK-LIKE STATE" WITH HYPOTONICITY, HYPORESPONSIVENESS, AND SHORT-LIVED CONVULS ... -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- REFERENCES -- 7 Evidence Concerning Rubella Vaccines and Arthritis, Radiculoneuritis, and Thrombocytopenic Purpura -- ARTHRITIS -- Clinical Description and Pathologic Aspects -- Descriptive Epidemiology -- History of an Association with Rubella Vaccines -- Evidence from Studies in Humans -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Evidence from Studies in Animals -- Possible Mechanisms -- Summary -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Conclusions -- RADICULONEURITIS AND OTHER NEUROPATHIES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- THROMBOCYTOPENIC PURPURA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- REFERENCES -- Afterword on Research Needs -- Bibliography -- Glossary of Terms B -- Appendixes. A Strategies For Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines -- LITERATURE SEARCHES -- Electronic Data Bases -- OTHER SOURCES -- Reference Lists -- Presentations -- Public Meeting (January 10, 1990) -- Workshop (May 14, 1990) -- Committee Meeting (May 15, 1990) -- Additional Individuals and Organizations Who Provided Information -- Review of Interim Bibliography -- ABSTRACTION OF DATA FROM CASE REPORTS, CASE SERIES, AND CONTROLLED STUDIES -- Rationale -- Procedures for Abstraction and Adjudication of Study Data -- B Pertussis and Rubella Vaccines: A Brief Chronology -- PERTUSSIS VACCINES -- RUBELLA VACCINES -- REFERENCES -- C Animal Models for the Study of Whooping Cough and the Testing of Vaccine Materials -- ANIMAL MODELS FOR THE STUDY OF WHOOPING COUGH -- STANDARDIZED ANIMAL TESTS OF VACCINE MATERIALS -- REFERENCES -- D Technical Details of Power Calculations and Meta-Analyses -- POWER CALCULATIONS -- META-ANALYSES -- Formal Analysis -- Informal Analysis -- REFERENCES -- E Possible Involvement of Aluminum Salts in Erythema Multiforme, Encephalopathy, or Other Adverse E ... -- REFERENCES -- F Committee and Staff Biographies -- COMMITTEE -- STAFF -- Index. |
| Record Nr. | UNINA-9911147080303321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Control of cardiovascular diseases in Developing countries [[electronic resource] ] : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors
| Control of cardiovascular diseases in Developing countries [[electronic resource] ] : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1998 |
| Descrizione fisica | xvi, 86 p. : ill |
| Disciplina | 362.1/961/0091724 |
| Altri autori (Persone) | HowsonChristopher Paul |
| Soggetto topico |
Cardiovascular system - Diseases - Epidemiology
Cardiovascular system - Diseases - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-18677-1
9786610186778 0-309-59207-0 0-585-03755-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910455839703321 |
| Washington, D.C., : National Academy Press, 1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Control of cardiovascular diseases in developing countries [[electronic resource] ] : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors
| Control of cardiovascular diseases in developing countries [[electronic resource] ] : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1998 |
| Descrizione fisica | xvi, 86 p. : ill |
| Disciplina | 362.1/961/0091724 |
| Altri autori (Persone) | HowsonChristopher Paul |
| Soggetto topico |
Cardiovascular system - Diseases - Epidemiology
Cardiovascular system - Diseases - Prevention |
| ISBN |
0-309-17381-7
1-280-18677-1 9786610186778 0-309-59207-0 0-585-03755-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778752503321 |
| Washington, D.C., : National Academy Press, 1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Control of cardiovascular diseases in Developing countries : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors
| Control of cardiovascular diseases in Developing countries : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1998 |
| Descrizione fisica | xvi, 86 p. : ill |
| Disciplina | 362.1/961/0091724 |
| Altri autori (Persone) | HowsonChristopher Paul |
| Soggetto topico |
Cardiovascular system - Diseases - Epidemiology
Cardiovascular system - Diseases - Prevention |
| ISBN |
9786610186778
9780309173810 0309173817 9781280186776 1280186771 9780309592079 0309592070 9780585037554 0585037558 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Control of Cardiovascular Diseases in Developing Countries -- Copyright -- Preface -- PROJECT CHARGE -- ORGANIZATION OF THE REPORT -- Acknowledgments -- Contents -- Control of Cardiovascular Diseases in Developing Countries -- Executive Summary -- RECOMMENDATIONS -- Determine the Magnitude of the CVD Burden in Developing Countries -- Develop Targeted, Effective Primordial and Primary Prevention StrategiesUsing Case-Control Studies -- Reduce Tobacco Use -- Detect and Treat High Blood Pressure -- Initiate Pilot Studies to Evaluate Essential Vascular Packages of Effective, Low-Cost Drugs -- Develop and Assess Algorithms of Affordable Clinical Care for CVD -- Build the Capacity to Conduct R& -- D Activities -- Develop Institutional Mechanisms for Facilitating CVD Prevention and Control -- 1 The Current Burden of Cardiovascular Diseases in Developing Countries -- ECONOMIC DEVELOPMENT BRINGS CHANGES -- ATHEROSCLEROSIS AS THE UNDERLYING DISEASE PROCESS -- Risk Factors for Atherosclerotic Disease -- THE GLOBAL BURDEN -- Cardiovascular Disease as the Leading Cause of Death -- Another Measure of Disease Burden -- Regional Differences -- Attributable Risk -- CONCLUSIONS -- 2 The Future Burden of Cardiovascular Diseases in Developing Countries -- PROJECTIONS OF THE FUTURE BURDEN -- Future Impact of Tobacco -- Future Effects of Other CVD Risk Factors -- CAN DEVELOPING COUNTRIES AVOID THE FUTURE BURDEN? -- Cardiovascular Disease Prevention Strategies -- Efficacy of Current Interventions -- ECONCOMIC CONSEQUENCES -- COST-EFFECTIVENESS OF PREVENTION AND TREATMENT -- 3 Prevention and Treatment of Cardiovascular Diseases in Developing Countries -- DIFFICULTIES IN ASSESSING PATTERNS -- THE ROLE OF INTERNATIONALLY SPONSORED PROGRAMS -- THE ROLE OF THE PRIVATE SECTOR -- ZAMBIA: A CASE STUDY -- FUTURE DIRECTIONS.
4 Current Research and Development in Developing Countries -- 5 Priorities for Global Research and Development -- CONTEXT -- RESEARCH PRIORITIES -- Improve Knowledge of the Size of the CVD Burden in Developing Countries -- Vital Registration -- Cause-of-Death Statistics -- Disability Estimates -- Establishing the Levels, Determinants, and Consequences of Risk Factors -- Cross-Sectional Surveys -- Analytic Studies -- Public Health Interventions -- Randomized Trials -- Clinical Interventions -- Essential Vascular Package -- Algorithms for Effective Diagnosis and Clinical Management -- Randomized Trials of Other Low-Cost Treatments -- Inclusion of Developing Countries in International Collaborative Clinical Trials -- Other Public Health Interventions -- RESEARCH TO CONTROL SPECIFIC RISK FACTORS -- Tobacco Use -- Hypertension -- Diet and Physical Activity -- HEALTH SERVICES RESEARCH -- Review of Patterns of Clinical Practice -- The Economic Burden and Cost-Effectiveness of Interventions -- GOVERNMENT'S POLICY ROLE -- Tobacco Control Policy -- Food and Nutrition Policy -- Pharmaceutical Policy -- Private-Sector Participation -- BUILDING CAPACITY FOR RESEARCH AND DEVELOPMENT -- 6 Institutional Arrangements for Research and Development -- EFFECTIVE RESEARCH AND DEVELOPMENT AT LOCAL OR NATIONAL, REGIONAL, AND GLOBAL LEVELS -- MODELS OF INTERNATIONAL COLLABORATION -- The Special Programme for Research and Training in Tropical Diseases -- The MONICA Project -- DEVELOPMENT OF AN INSTITUTIONAL MECHANISM FOR CARDIOVASCULAR RESEARCH AND DEVELOPMENT -- Epilogue -- ECONOMIC IMPACT -- ETHICAL CONCERN: THE CONCEPT OF HEALTH FOR ALL -- NATIONAL RELEVANCE -- SCIENTIFIC DISCOVERY -- GLOBAL HEALTH ISSUES -- References -- Appendix A Five Steps for Setting Research Priorities -- STEP 1: DETERMINE THE SIZE OF THE CVD BURDEN -- STEP 2: IDENTIFY THE REASONS FOR THE CVD BURDEN. STEP 3: EVALUATE THE ADEQUACY OF THE CURRENT KNOWLEDGE BASE -- STEP 4: EVALUATE THE PROMISE OF R& -- D EFFORTS -- STEP 5: ASSESS THE ADEQUACY OF THE CURRENT LEVEL OF EFFORT -- Appendix B Glossary of Cardiologic and Epidemiologic Terms -- CLINICAL MANIFESTATIONS OF ATHEROSCLEROTIC CARIOVASCULAR DISEASE -- Diseases That May Be Due to Effects of Hypertension on the Cardiovascular System -- CARIOVASCULAR RISK FACTORS -- EPIDEMIOLOGIC TERMS AND CONCEPTS. |
| Altri titoli varianti | Cardiovascular diseases in developing countries |
| Record Nr. | UNINA-9911110609703321 |
| Washington, D.C., : National Academy Press, 1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Control of cardiovascular diseases in Developing countries : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors
| Control of cardiovascular diseases in Developing countries : research, development, and institutional strengthening / / Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Board on International Health, Institute of Medicine ; Christopher P. Howson ... [et al.], editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1998 |
| Descrizione fisica | xvi, 86 p. : ill |
| Disciplina | 362.1/961/0091724 |
| Altri autori (Persone) | HowsonChristopher Paul |
| Soggetto topico |
Cardiovascular system - Diseases - Epidemiology
Cardiovascular system - Diseases - Prevention |
| ISBN |
9786610186778
9780309173810 0309173817 9781280186776 1280186771 9780309592079 0309592070 9780585037554 0585037558 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Control of Cardiovascular Diseases in Developing Countries -- Copyright -- Preface -- PROJECT CHARGE -- ORGANIZATION OF THE REPORT -- Acknowledgments -- Contents -- Control of Cardiovascular Diseases in Developing Countries -- Executive Summary -- RECOMMENDATIONS -- Determine the Magnitude of the CVD Burden in Developing Countries -- Develop Targeted, Effective Primordial and Primary Prevention StrategiesUsing Case-Control Studies -- Reduce Tobacco Use -- Detect and Treat High Blood Pressure -- Initiate Pilot Studies to Evaluate Essential Vascular Packages of Effective, Low-Cost Drugs -- Develop and Assess Algorithms of Affordable Clinical Care for CVD -- Build the Capacity to Conduct R& -- D Activities -- Develop Institutional Mechanisms for Facilitating CVD Prevention and Control -- 1 The Current Burden of Cardiovascular Diseases in Developing Countries -- ECONOMIC DEVELOPMENT BRINGS CHANGES -- ATHEROSCLEROSIS AS THE UNDERLYING DISEASE PROCESS -- Risk Factors for Atherosclerotic Disease -- THE GLOBAL BURDEN -- Cardiovascular Disease as the Leading Cause of Death -- Another Measure of Disease Burden -- Regional Differences -- Attributable Risk -- CONCLUSIONS -- 2 The Future Burden of Cardiovascular Diseases in Developing Countries -- PROJECTIONS OF THE FUTURE BURDEN -- Future Impact of Tobacco -- Future Effects of Other CVD Risk Factors -- CAN DEVELOPING COUNTRIES AVOID THE FUTURE BURDEN? -- Cardiovascular Disease Prevention Strategies -- Efficacy of Current Interventions -- ECONCOMIC CONSEQUENCES -- COST-EFFECTIVENESS OF PREVENTION AND TREATMENT -- 3 Prevention and Treatment of Cardiovascular Diseases in Developing Countries -- DIFFICULTIES IN ASSESSING PATTERNS -- THE ROLE OF INTERNATIONALLY SPONSORED PROGRAMS -- THE ROLE OF THE PRIVATE SECTOR -- ZAMBIA: A CASE STUDY -- FUTURE DIRECTIONS.
4 Current Research and Development in Developing Countries -- 5 Priorities for Global Research and Development -- CONTEXT -- RESEARCH PRIORITIES -- Improve Knowledge of the Size of the CVD Burden in Developing Countries -- Vital Registration -- Cause-of-Death Statistics -- Disability Estimates -- Establishing the Levels, Determinants, and Consequences of Risk Factors -- Cross-Sectional Surveys -- Analytic Studies -- Public Health Interventions -- Randomized Trials -- Clinical Interventions -- Essential Vascular Package -- Algorithms for Effective Diagnosis and Clinical Management -- Randomized Trials of Other Low-Cost Treatments -- Inclusion of Developing Countries in International Collaborative Clinical Trials -- Other Public Health Interventions -- RESEARCH TO CONTROL SPECIFIC RISK FACTORS -- Tobacco Use -- Hypertension -- Diet and Physical Activity -- HEALTH SERVICES RESEARCH -- Review of Patterns of Clinical Practice -- The Economic Burden and Cost-Effectiveness of Interventions -- GOVERNMENT'S POLICY ROLE -- Tobacco Control Policy -- Food and Nutrition Policy -- Pharmaceutical Policy -- Private-Sector Participation -- BUILDING CAPACITY FOR RESEARCH AND DEVELOPMENT -- 6 Institutional Arrangements for Research and Development -- EFFECTIVE RESEARCH AND DEVELOPMENT AT LOCAL OR NATIONAL, REGIONAL, AND GLOBAL LEVELS -- MODELS OF INTERNATIONAL COLLABORATION -- The Special Programme for Research and Training in Tropical Diseases -- The MONICA Project -- DEVELOPMENT OF AN INSTITUTIONAL MECHANISM FOR CARDIOVASCULAR RESEARCH AND DEVELOPMENT -- Epilogue -- ECONOMIC IMPACT -- ETHICAL CONCERN: THE CONCEPT OF HEALTH FOR ALL -- NATIONAL RELEVANCE -- SCIENTIFIC DISCOVERY -- GLOBAL HEALTH ISSUES -- References -- Appendix A Five Steps for Setting Research Priorities -- STEP 1: DETERMINE THE SIZE OF THE CVD BURDEN -- STEP 2: IDENTIFY THE REASONS FOR THE CVD BURDEN. STEP 3: EVALUATE THE ADEQUACY OF THE CURRENT KNOWLEDGE BASE -- STEP 4: EVALUATE THE PROMISE OF R& -- D EFFORTS -- STEP 5: ASSESS THE ADEQUACY OF THE CURRENT LEVEL OF EFFORT -- Appendix B Glossary of Cardiologic and Epidemiologic Terms -- CLINICAL MANIFESTATIONS OF ATHEROSCLEROTIC CARIOVASCULAR DISEASE -- Diseases That May Be Due to Effects of Hypertension on the Cardiovascular System -- CARIOVASCULAR RISK FACTORS -- EPIDEMIOLOGIC TERMS AND CONCEPTS. |
| Altri titoli varianti | Cardiovascular diseases in developing countries |
| Record Nr. | UNINA-9911147341503321 |
| Washington, D.C., : National Academy Press, 1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Estimated mean per capita energy requirements for planning emergency food aid rations [[electronic resource] /] / Committee on International Nutrition, Food and Nutrition Board, Board on International Health, Institute of Medicine ; Lindsay H. Allen and Christopher P. Howson, editors
| Estimated mean per capita energy requirements for planning emergency food aid rations [[electronic resource] /] / Committee on International Nutrition, Food and Nutrition Board, Board on International Health, Institute of Medicine ; Lindsay H. Allen and Christopher P. Howson, editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1995 |
| Descrizione fisica | 1 online resource (45 p.) |
| Disciplina | 353.56 |
| Altri autori (Persone) |
AllenLindsay <1946->
HowsonChristopher Paul |
| Soggetto topico |
Food relief - United States
Nutrition policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN | 9786610258604 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Estimated Mean per Capita Energy Requirements for Planning Emergency Food Aid Rations""; ""Copyright""; ""Preface""; ""CHARGE TO THE COMMITTEE""; ""ORGANIZATION OF THE REPORT""; ""ACKNOWLEDGMENTS""; ""Contents""; ""1 Background""; ""PROJECT DESCRIPTION AND SCOPE""; ""MOTIVATION FOR THE SCOPE CHOSEN""; ""2 Estimating Energy Requirements of Refugee and Other Populations Requiring Food Aid""; ""HISTORICAL VIEW OF ENERGY RECOMMENDATIONS""; ""ESTIMATING ENERGY REQUIREMENTS OF INDIVIDUALS""; ""Determinants of Energy Requirements""; ""Basal Metabolic Rate""; ""Physical Activity""
""Estimating Activity Levels of Refugees and Displaced Persons""""Energy Requirements for Growth, Pregnancy, and Lactation""; ""ESTIMATING ENERGY REQUIREMENTS OF POPULATIONS""; ""Theoretical Approach: Calculating the Estimated Mean per Capita Energy Requirement""; ""Calculation of the Committee's EMPCER for Use in Emergency Situations""; ""Impact of Changing Underlying Assumptions for Adjustment of the EMPCER""; ""Demographic Distribution""; ""Body Size""; ""Physical Activity Level""; ""Adjustment for Breastfeeding""; ""Adjustment for Recovery from Malnutrition and for Cold Environments"" ""3 Summary and Recommendations""""References""; ""Appendix USAID's Request to the Committee""; ""MEMORANDUM FROM SAMUEL G. KAHN DATED 7 SEPTEMBER 1994""; ""MEMORANDUM FROM TOM MARCHIONE DATED 7 SEPTEMBER 1994""; ""Background""; ""Issue""; ""Request for Professional Determination"" |
| Record Nr. | UNINA-9910451794003321 |
| Washington, D.C., : National Academy Press, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Estimated mean per capita energy requirements for planning emergency food aid rations [[electronic resource] /] / Committee on International Nutrition, Food and Nutrition Board, Board on International Health, Institute of Medicine ; Lindsay H. Allen and Christopher P. Howson, editors
| Estimated mean per capita energy requirements for planning emergency food aid rations [[electronic resource] /] / Committee on International Nutrition, Food and Nutrition Board, Board on International Health, Institute of Medicine ; Lindsay H. Allen and Christopher P. Howson, editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1995 |
| Descrizione fisica | 1 online resource (45 p.) |
| Disciplina | 353.56 |
| Altri autori (Persone) |
AllenLindsay <1946->
HowsonChristopher Paul |
| Soggetto topico |
Food relief - United States
Nutrition policy - United States |
| ISBN | 9786610258604 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Estimated Mean per Capita Energy Requirements for Planning Emergency Food Aid Rations""; ""Copyright""; ""Preface""; ""CHARGE TO THE COMMITTEE""; ""ORGANIZATION OF THE REPORT""; ""ACKNOWLEDGMENTS""; ""Contents""; ""1 Background""; ""PROJECT DESCRIPTION AND SCOPE""; ""MOTIVATION FOR THE SCOPE CHOSEN""; ""2 Estimating Energy Requirements of Refugee and Other Populations Requiring Food Aid""; ""HISTORICAL VIEW OF ENERGY RECOMMENDATIONS""; ""ESTIMATING ENERGY REQUIREMENTS OF INDIVIDUALS""; ""Determinants of Energy Requirements""; ""Basal Metabolic Rate""; ""Physical Activity""
""Estimating Activity Levels of Refugees and Displaced Persons""""Energy Requirements for Growth, Pregnancy, and Lactation""; ""ESTIMATING ENERGY REQUIREMENTS OF POPULATIONS""; ""Theoretical Approach: Calculating the Estimated Mean per Capita Energy Requirement""; ""Calculation of the Committee's EMPCER for Use in Emergency Situations""; ""Impact of Changing Underlying Assumptions for Adjustment of the EMPCER""; ""Demographic Distribution""; ""Body Size""; ""Physical Activity Level""; ""Adjustment for Breastfeeding""; ""Adjustment for Recovery from Malnutrition and for Cold Environments"" ""3 Summary and Recommendations""""References""; ""Appendix USAID's Request to the Committee""; ""MEMORANDUM FROM SAMUEL G. KAHN DATED 7 SEPTEMBER 1994""; ""MEMORANDUM FROM TOM MARCHIONE DATED 7 SEPTEMBER 1994""; ""Background""; ""Issue""; ""Request for Professional Determination"" |
| Record Nr. | UNINA-9910777424903321 |
| Washington, D.C., : National Academy Press, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
